Clayton Partners LLC Abb Vie Inc. Transaction History

Clayton Partners LLC

$125 Million
Q3 2024

A detailed history of Clayton Partners LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Clayton Partners LLC holds 20,080 shares of ABBV stock, worth $3.53 Million. This represents 3.18% of its overall portfolio holdings.

Number of Shares

20,080

Previous 20,244 0.81%

Holding current value

$3.53 Million

Previous $3.47 Million 14.2%

% of portfolio

3.18%

Previous 3.1%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$163.84 - $199.33 $26,869 - $32,690	-164 Reduced 0.81%	20,080 $3.97 Million
Q2 2024 Aug 13, 2024	SELL	$154.79 - $180.76 $35,137 - $41,032	-227 Reduced 1.11%	20,244 $3.47 Million
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $625,375 - $712,557	-3,913 Reduced 16.05%	20,471 $3.73 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $2,614 - $2,944	19 Added 0.08%	24,384 $3.78 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $78,016 - $90,315	584 Added 2.46%	24,365 $3.63 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $20,804 - $25,889	-157 Reduced 0.66%	23,781 $3.2 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $9,833 - $11,324	68 Added 0.28%	23,938 $3.81 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $74,964 - $89,901	542 Added 2.32%	23,870 $3.86 Million
Q3 2022 Nov 09, 2022	BUY	$134.21 - $153.93 $10,468 - $12,006	78 Added 0.34%	23,328 $3.13 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $6,055 - $7,698	-44 Reduced 0.19%	23,250 $3.56 Million
Q1 2022 May 12, 2022	BUY	$131.98 - $163.75 $106,507 - $132,146	807 Added 3.59%	23,294 $3.78 Million
Q4 2021 Feb 07, 2022	BUY	$107.43 - $135.93 $35,451 - $44,856	330 Added 1.49%	22,487 $3.05 Million
Q3 2021 Nov 16, 2021	SELL	$106.4 - $120.78 $851 - $966	-8 Reduced 0.04%	22,157 $2.39 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $81,222 - $90,486	772 Added 3.61%	22,165 $2.5 Million
Q1 2021 May 12, 2021	BUY	$102.3 - $112.62 $2.19 Million - $2.41 Million	21,393 New	21,393 $2.32 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clayton Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clayton Partners LLC with notifications on news.

Account

Clayton Partners LLC Abb Vie Inc. Transaction History